GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®.

Competing Interests: Declarations Ethics approval and consent to participate The work was performed using the database, Vigibase® which is freely available to the author. No informed consent was required from patients since the database Vigibase® is anonymized. Institutional review board approval was not required because Vigibase® is an anonymized database open to pharmacovigilance centers. Patients’ informed consent was not necessary since data from VigiBase® were deidentified. According to French law, a review from an ethics committee is not required for such observational studies. Competing interests The authors declare no competing interests. Sponsor role No sponsor for this research work. Principal investigator The author confirms that the principal investigator for this paper was Professor Jean-Louis Montastruc. No direct clinical responsibility for patients was needed since the work was performed using the global pharmacovigilance database, VigiBase®.